cta_explore-pathway-m

For U.S. healthcare professionals only

Leave a Reply Cancel reply

REFERENCES

Garcia-Montero AC, et al. Blood. 2006;108(7):2366-2372.
Verstovsek S. Eur J Haematol. 2013;90(2):89-98.
Gilreath JA, et al. Clin Pharmacol. 2019;11:77-92.
Metcalfe DD. Blood. 2008;112(4):946-956.
Theoharides TC, et al. N Engl J Med. 2015;373(2):163-172.
Hartmann K, et al. J Allergy Clin Immunol. 2016;137(1):35-45.
Shomali W, Gotlib J. Hematology Am Soc Hematol Educ Program. 2018(1):127-136.
Lim KH, et al. Blood. 2009;113(23):5727-5736.
Kibsgaard L, et al. Derm. 2020;6:294-300.
Sperr WR, et al. Lancet Haematol. 2019;6(12):e638-e649.
Trizuljak J, et al. Allergy. 2020;75(8):1927-1938.
Arock M, et al. Leukemia. 2015;29(6):1223-1232.
Hermine O, et al. PLoS One. 2008;3(5):e2266.
Chatterjee A, et al. Oncotarget. 2015;6(21):18250-18264.
Arber DA, et al. Blood. 2016;127(20):2391-2405.
Swerdlow SH, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Rev 4th ed. International Agency for Research on Cancer (IARC); 2017.
da Silva EZ, et al. J Histochem Cytochem. 2014;62:698-738.
Valent P, et al. Blood. 2017;129(11):1420-1427.
Jennings SV, et al. Immunol Allergy Clin North Am. 2018;38(3):505-525.
Amin K. Respir Med. 2012;106(1):9-14.
Gulen T, et al. J Intern Med. 2016;279(3):211-228.
Mickys U, et al. Dig Liver Dis. 2007;39(7):693-697.
Akin C, Castells M; World Allergy Organization. July 2011. Updated March 2017. Accessed October 9, 2020. https://www.worldallergy.org/education-and-programs/education/allergic-disease-resource-center/professionals/mastocytosis-where-are-we-now.
Pardanani A, et al. Blood. 2010;115(1):150-151.
Pardanani A. Am J Hematol. 2013;88(7):612-624.
Data on file. Blueprint Medicines Corporation. Cambridge, MA. 2020.
Kristensen T, et al. Am J Hematol. 2014;89(5):493-498.
van Anrooij B, et al. Allergy. 2016;71(11):1585-1593.
Vos B, et al. J Allergy Clin Immunol Pract. 2017;5(5):1264-1271.
Berezowska S, et al. Mod Pathol. 2014;27(1):19-29.
Gulen T, et al. J Allergy Clin Immunol Pract. 2017;5:1248-1255.
Hahn HP, Hornick JL. Am J Surg Pathol. 2007;31(11):1669-1676.
Craig JW, et al. Mod Pathol. 2020;133(6):1135-1145.
Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines^®) for Systemic Mastocytosis V.1.2020. ©National Comprehensive Cancer Network, Inc. 2020. All rights reserved. Accessed September 11, 2020. To view the most recent and complete version of the guideline, go online to NCCN.org. NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.
Pardanani A. Am J Hematol. 2019;94(3):363-377.
Akin C, Valent P. Immunol Allergy Clin North Am. 2014;34(2):207-218.
Valent P, et al. Int J Mol Sci. 2019;20(12):2976.
Akin C. J Mol Diagn. 2006;8(4):412-419.

This website is intended for U.S. healthcare professionals only. This website does not provide medical advice and is for educational purposes only.

Blueprint Medicines and associated logo are trademarks of Blueprint Medicines Corporation.

All other trademarks are the property of their respective owners.

04/2021 USBP-PRSM-20.011.3

cta_explore-pathway-m

Leave a Reply Cancel reply

UncoverKIT and the information contained in this site are intended for U.S. healthcare professionals only.

You are about to leave UncoverKIT.com